Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. (2022)
Attributed to:
Viral Hepatitis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2022.100739
PubMed Identifier: 36075216
Publication URI: http://europepmc.org/abstract/MED/36075216
Type: Journal Article/Review
Volume: 3
Parent Publication: Cell reports. Medicine
Issue: 9
ISSN: 2666-3791